Global Cardiac Marker Testing Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Report Code: KNJ920383 No. of Pages: 92 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Executive Summary
According to GRD Survey data, the global Cardiac Marker Testing market was valued at million US$ in 2020 and is expected to million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.
This report studies the Cardiac Marker Testing market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of Cardiac Marker Testing in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Chemiluminescence
Immunofluorescence
ELISA
Immunochromatography
Others
Market Snapshot, By Application
Pharmaceutical Companies
Reagents Manufacturers
Imaging Instrument Providers
Others
Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia
Main Market Players Analyzed in this report, including:
Siemens
Roche Diagnostics
Randox Laboratories Ltd
Ortho Clinical Diagnostics
LSI Medience Corporation
Guangzhou Wondfo Biotech
Danaher Corporation
BioMerieux
Alere Inc
Abbott Laboratories
The study objectives of this report are:
To study and analyze the global Cardiac Marker Testing market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Cardiac Marker Testing market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Cardiac Marker Testing manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cardiac Marker Testing market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Cardiac Marker Testing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Cardiac Marker Testing are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Cardiac Marker Testing Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Cardiac Marker Testing Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Cardiac Marker Testing
3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Pharmaceutical Companies
3.2.2 Major Buyers in Reagents Manufacturers
4 Market Segment: by Type
4.1 Cardiac Marker Testing Type Introduction
4.1.1 Chemiluminescence
4.1.2 Immunofluorescence
4.1.3 ELISA
4.1.4 Immunochromatography
4.1.5 Others
4.2 Global Cardiac Marker Testing Revenue by Type 2016-2021
5 Market Segment: by Application
5.1 Cardiac Marker Testing Type Introduction
5.1.1 Pharmaceutical Companies
5.1.2 Reagents Manufacturers
5.1.3 Imaging Instrument Providers
5.1.3 Others
5.2 Global Cardiac Marker Testing Revenue by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Cardiac Marker Testing Market by Region
6.2 North America Cardiac Marker Testing Market 2016-2021
6.3 Europe Cardiac Marker Testing Market 2016-2021
6.4 Asia Pacific Cardiac Marker Testing Market 2016-2021
6.5 South America Cardiac Marker Testing Market 2016-2021
6.6 Middle East and Africa Cardiac Marker Testing Market 2016-2021
7 North America
7.1 North America Cardiac Marker Testing Market by Country 2016-2021
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Cardiac Marker Testing Market by Country 2016-2021
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Cardiac Marker Testing Market by Country 2016-2021
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Cardiac Marker Testing Market by Country 2016-2021
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Cardiac Marker Testing Market by Country 2016-2021
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 Siemens
12.1.1 Siemens
Company Information
12.1.2 Siemens
Cardiac Marker Testing Product Portfolio, Specification and Application
12.1.3 Siemens
Cardiac Marker Testing Revenue and Gross Margin (2019-2021)
12.1.4 Siemens
Key Development
12.2 Roche Diagnostics
12.2.1 Roche Diagnostics
Company Information
12.2.2 Roche Diagnostics
Cardiac Marker Testing Product Portfolio, Specification and Application
12.2.3 Roche Diagnostics
Cardiac Marker Testing Revenue and Gross Margin (2019-2021)
12.2.4 Roche Diagnostics
Key Development
12.3 Randox Laboratories Ltd
12.3.1 Randox Laboratories Ltd
Company Information
12.3.2 Randox Laboratories Ltd
Cardiac Marker Testing Product Portfolio, Specification and Application
12.3.3 Randox Laboratories Ltd
Cardiac Marker Testing Revenue and Gross Margin (2019-2021)
12.3.4 Randox Laboratories Ltd
Key Development
12.4 Ortho Clinical Diagnostics
12.4.1 Ortho Clinical Diagnostics
Company Information
12.4.2 Ortho Clinical Diagnostics
Cardiac Marker Testing Product Portfolio, Specification and Application
12.4.3 Ortho Clinical Diagnostics
Cardiac Marker Testing Revenue and Gross Margin (2019-2021)
12.4.4 Ortho Clinical Diagnostics
Key Development
12.5 LSI Medience Corporation
12.5.1 LSI Medience Corporation
Company Information
12.5.2 LSI Medience Corporation
Cardiac Marker Testing Product Portfolio, Specification and Application
12.5.3 LSI Medience Corporation
Cardiac Marker Testing Revenue and Gross Margin (2019-2021)
12.5.4 LSI Medience Corporation
Key Development
12.6 Guangzhou Wondfo Biotech
12.6.1 Guangzhou Wondfo Biotech
Company Information
12.6.2 Guangzhou Wondfo Biotech
Cardiac Marker Testing Product Portfolio, Specification and Application
12.6.3 Guangzhou Wondfo Biotech
Cardiac Marker Testing Revenue and Gross Margin (2019-2021)
12.6.4 Guangzhou Wondfo Biotech
Key Development
12.7 Danaher Corporation
12.7.1 Danaher Corporation
Company Information
12.7.2 Danaher Corporation
Cardiac Marker Testing Product Portfolio, Specification and Application
12.7.3 Danaher Corporation
Cardiac Marker Testing Revenue and Gross Margin (2019-2021)
12.7.4 Guangzhou Wondfo Biotech
Key Development
12.9 Alere Inc
12.9.1 Alere Inc
Company Information
12.9.2 Alere Inc
Cardiac Marker Testing Product Portfolio, Specification and Application
12.9.3 Alere Inc
Cardiac Marker Testing Revenue and Gross Margin (2019-2021)
12.9.4 Alere Inc
Key Development
12.8 BioMerieux
12.8.1 BioMerieux
Company Information
12.8.2 BioMerieux
Cardiac Marker Testing Product Portfolio, Specification and Application
12.8.3 BioMerieux
Cardiac Marker Testing Revenue and Gross Margin (2019-2021)
12.8.4 BioMerieux
Key Development
13 Global Cardiac Marker Testing Market Forecast by Region by Type and by Application
13.1 Global Cardiac Marker Testing Revenue Forecast 2022-2027
13.2 Global Cardiac Marker Testing Forecast by Regions
13.3 Global Cardiac Marker Testing Forecast by Type
13.4 Global Cardiac Marker Testing Forecast by Application
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com